This is the production release of the second iteration of EudraCT 8.1. It includes the following main functional changes:

Similar documents
Standard operating procedure

Lead Author Approver Effective Date: 13-MAR-13 Name: Ana Rodriguez Sanchez Review Date: 13-MAR-16

Applies to: SA Administrative Assistant, SAWP Scientific Secretary and SA secretarial team in Scientific Advice Section

All external requests for access to information as well as their responses are entered into the Queries database.

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies

esubmissions Web UI Release Notes

Mock-ups checklist - Guidance for checking mock-ups

EUDRACT V7.0 USER MANUAL (PUBLIC WEBSITE)

Standard operating procedure

All the documents related to the EU-RMP Annex 1 activities are stored at the following locations:

esubmissions Web UI Release Notes

How to send submissions via the Web Client

Standard operating procedure

Standard operating procedure

SUBMISSION OF COMMENTS ON Guideline on Real Time Release Testing (formerly Guideline on Parametric Release) Draft

IRIS Quick guide to the portal for Orphan Industry users

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Documents needed for this WIN

User guide on how to generate PDF versions of the product information - veterinary

EUDRACT USER MANUAL (PUBLIC WEBSITE)

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 04/02/2019)... 7

EudraVigilance Release Notes v.1.13

EudraCT release notes

Standard operating procedure

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide

SUBMISSION OF COMMENTS ON

Standard operating procedure

extended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step Guide

Management of RMP for CAPs in postauthorisation

Standard operating procedure

Title: Handling of Art. 29(1) referrals to the CMDh (60 day procedure) by the CMDh secretariat (incl. Article 13 referrals for variations)

3 September

IRIS Quick guide to registration

Date: May 19, Dear Dr. Domingo,

eaf Release notes Table of Contents Version (Release Date: 28/09/2018)... 7 Version (Release Date: 13/07/2018)...

Guidance for submission and validation of electronic declaration of interests and electronic curriculum vitae

Title: Key activities when screening the electronic Reaction Monitoring Reports (ermrs) for new signals

Chapter 5: Extended EudraVigilance Product Report Acknowledgement Message

EUROPEAN MEDICINES AGENCY (EMA) CONSULTATION

EudraVigilance Components & Functionality Introduction

eaf Release Notes Table of Contents Version (Release Date: 13/07/2018)... 7 Version (Release Date: 16/02/2018)...

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS FOR PLASMA MASTER FILE (PMF) CERTIFICATION

Citrix Remote Access

Process description for managing duplicates in the context of the Medical Literature Monitoring (MLM) service

On-boarding of users to SPOR data services

ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD. Step 5

eaf Release notes Table of Contents Version (Release Date: 16/02/2018)... 7 Version (Release Date: 15/12/2017)...

eaf Release notes Table of Contents Version (Release Date: 13/07/2018)... 7 Version (Release Date: 16/02/2018)...

September 2015 Ginas Meeting Highlights

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 28/09/2018)... 7

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 13/07/2018)... 7

Display the XML Files for Disclosure to Public by Using User-defined XSL Zhiping Yan, BeiGene, Beijing, China Huadan Li, BeiGene, Beijing, China

Multinational assessment teams

QP Current Practices, Challenges and Mysteries. Caitriona Lenagh 16 March 2012

PMS Iteration 1: analysis of the data efforts & value results and recommendation on the scope

PSUR Repository and the EU single assessment

CRSTAR TREATMENT SUMMARY AND CUSTOM FORMS

Standard operating procedure

Cover note on XEVMPD substance controlled vocabulary following the quality control exercise

Managing Contacts in Cisco Unified Personal Communicator

esubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions

The WIN applies to the Vet Applications team in the Veterinary Regulatory and Organisational Support service (V-VM-ROS).

OMS Data Quality Standard

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool (EVWEB) user manual

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office SOP 1027 LU

Welcome to the portal. We are very pleased for your interest in our vacancies.

PSUR Repository Implementation Plan

ENCePP Code of Conduct Implementation Guidance for Sharing of ENCePP Study Data

Monash University Policy Management. User Guide

List of nationally authorised medicinal products

User Guidance for National Competent Authorities for PSUR Repository

SmPC and. & New QRD. Spanish Medicines Agency (AEMPS)

NZ Online Forms for Research Software Manual

Comments received from public consultation on good pharmacovigilance practices (GVP)

Measures for Article 57 Data Quality Assurance

EUDRACT USER MANUAL (GET EUDRACT NUMBER)

European Prize for Innovation in Public Administration

Sourcing - How to Create a Negotiation

Standard Operating Procedure. SOP full title: Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions

IBC Reviewer User Guide

EudraVigilance - EVWEB User Manual

Activation Modules. Table of Contents:

MT+ Beneficiary Guide

User Guidance for submissions via esubmission Gateway / Web Client using xml delivery files

OC RDC 4.6. User Guide

Legistar Administration Guide

Mobile Usability Testing. August 2015

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning

European Medicines Agency Standard Operating Procedure

Site Manager. Helpdesk/Ticketing

IBC Committee Manager User Guide

EMA Common Repository: Questions and answers relating to practical and technical aspects of the implementation

Submissions to the PSUR Repository using EMA Gateway/Web Client

Standard operating procedure

DG pre / R&D division Tel.: 02/ Fax: 02/

LaserFiche Appointments Manual

Quick Start Guide To Mobility Tool+ For Key Action 1 School Staff Mobility Projects Version 1

EudraVigilance - EVWEB User Manual

Annex IX: E-SUBMISSION THROUGH THE COMMON EUROPEAN PORTAL (CESP)

Protocol Management System (PMS) Investigator User Guide. Harris Health System Administrative Approval

PSUR Repository Interactive Q&A

Transcription:

9 September 2011 EMA/646917/2011 Release notes EudraCT Version: 8.1.1 Goal: Release 8.1 Iteration 2 Release Date: 12/09/11 Environment: Production (Public) Release Contents: This is the production release of the second iteration of EudraCT 8.1. It includes the following main functional changes: Further user interface improvements to enhance the design of data entry forms by eliminating manual data entry where information can be auto-populated and by hiding questions where not applicable as a result of answers in other parts of the form. To make viewing of a detailed CTA easier for users to read the view has been changed so that, for radio button fields, only the selected answer is shown (rather than displaying all radio button options even if they are unselected). Advisory text in grey now appears in other languages free text fields for EEA and 3rd Country forms. The text will advise: "Please enter information in other language that is applicable". The EEA PDF no longer shows Submission Reason section The release also includes some further changes to address identified defects in the main application and to address comments raised during user acceptance of 8.1 iteration 1. The impacted use cases / testable functionalities are listed below: Functionality / Use Case Comments BUC05 Fill in CT Application Form Enhanced form logic changes, expand / collapse and other UI changes BUC05 Fill in CT Application Form Further enhancements to form logic, help text changes and other UI improvements and defect fixes. 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8670 E-mail info@ema.europa.eu Website www.ema.europa.eu An agency of the European Union European Medicines Agency, 2011. Reproduction is authorised provided the source is acknowledged.

Functionality / Use Case BUC07 Download and Print PDF Comments Removal of unselected radio buttons in PDF output to make PDF easier to read. Note on PDF form to advise that D.3.6.1 and D.3.6.2 are legacy fields and to remove the data. Removal of Submission Reason from PDF form. BUC55 Validate 3 rd country CT Form Validation rule update to 3 rd Country form. BUC58 Validate Clinical Trial Application Validation rule update to EEA form. Below is the complete list of new features including improvements and help text changes, defect fixes identified and addressed in this release and technical improvements included in this release. Issue Type Priority Key Summary New Feature Critical ECT-3089 Text in Grey to appear in other languages free text fields for EEA & 3rd Country. The text will advise: "Please enter information in other language that is applicable" New Feature Major ECT-3071 Label change. E.8.7 Trial having a data monitoring committee Label changes to E.8.7 Trial having an independent data monitoring committee. This for both EEA & 3rd country screens. New Feature Major ECT-3077 BUC05 - Enhanced Form Logic / D.5 New Feature Major ECT-3078 BUC05 - Enhanced Form Logic / D.6 New Feature Major ECT-3079 BUC05 - Enhanced Form Logic / D.7 New Feature Major ECT-3080 BUC05 - Enhanced Form Logic / D.8 New Feature Major ECT-3087 BUC05 - Enhanced Form Logic / FEAT 21.8.32 - G.2.5.4 Country New Feature Major ECT-3088 BUC05 - Enhanced Form Logic / FEAT 21.8.33 - H.2.2.4 Country New Feature Major ECT-3092 BUC05 - Enhanced Form Logic / FEAT 6.2.1.55 E.8.2.4 New Feature Major ECT-3125 New tag to display help text for F.4.2 For a multinational trial Improvement Major ECT-3159 Label to be added to blue bar panel header for fields D.2.3, D.2.4, D.2.5, D.2.6 to make these fields easier to locate. EMA/745095/2011 Page 2/5

Major ECT-3165 C.2.1 And C.2.2 Sponsor Information/Legal Representative - Enhanced Form Logic - Automatic population of sponsor information if the sponsor is also an applicant. Similarly, automatic population of legal representative information if the legal representative is also an applicant. Defect Major ECT-3175 D.3.6.2 Maximum dose allowed - FEAT6.2.4 Validation rule relaxed for field D.3.6.2 as this is read only legacy data (non mandatory). Defect Major ECT-3178 Address defect from UAT of 8.1 iteration 1 - Help tool tips disappearing when error is encountered once a value is selected from C.1, C.2 drop down menu Defect Major ECT-3183 Address UAT comment from 8.1 iteration 1 - Add a green circle to B.3.1 and B.3.2 Status of the Sponsor. This field is public on the EU CTR for all trials Improvement Major ECT-3200 A.3.2 Name or abbreviated title of the trial where available - change to UI to make field longer Improvement Major ECT-3204 Revise the error message that currently appears on A.8 EMEA Decision Number to read as follows - A.8 EMA Decision number of Paediatric Investigation Plan: the value entered should have the format: P/xxx/yyyy where xxx is 1, 2 or 3 digits and yyyy represents years. The year value must be greater than 1999 and no more than 2099. Improvement Major ECT-3206 Revise error message on incorrect entry of field C.1.5.1 to make it clearer to the user. Major ECT-3212 EEA BA Template to hide Submission Reason section when creating PDF Defect Major ECT-3222 D.3.11.3.2 "Medical Product" to "Medicinal Product" Major ECT-3234 Legacy fields D.3.6.1 and D.3.6.2 (which were made read-only in 8.1 iteration 1) are no longer displayed in the CTA PDF output. Defect Major ECT-3225 On panel section labels "D.2.3", "D.2.4" and "D.2.6" removed for 3rd Country Clinical Trials (as not applicable) Defect Major ECT-3221 Defect fixed for BUC58: FEAT6.2.1.52 where rule was triggered when D.7.4.1 = No. Now, the rule is only triggered if D.7.4.1 is Yes and D.7.4.1.1 is "Not Answered". Improvement Major ECT-3235 to CTA output to sort G.1, G.2 investigator entries by their role EMA/745095/2011 Page 3/5

Defect Major ECT-3227 3rd Country PDF - incorrectly shows 'No' to IMP "Comparator'' when it should actually be Yes Major ECT-3236 Update Help Text - D.3.6.1 First Dose for first in human clinical trial Major ECT-3248 BI templates (Spanish translations) updated to be in line with cumulative changes that have been made to the English template. Defect Minor ECT-3161 If C.1.5.1.1 completed incorrectly then user is taken to CTA summary menu and error displayed rather than error being displayed in section C so fields can be amended (3rd Country only) Improvement Minor ECT-2889 Rename section C.1 of 3rd Country trial and Updates to the help text Defect Minor ECT-2924 Fix to minor discrepancy in text displayed on the UI and PDF output for 3rd Country screens (fields E.8.3 and E.8.4) Defect Minor ECT-3011 Support Call 110830 - Middle name in G.4 Networks to be involved in the trial should be optional. Defect Minor ECT-3151 Fix to comment raised in UAT v8.1 iteration 1 - change the EVMPD URL in the help text for D.2.1.1.1.1 Improvement Minor ECT-3155 Fix to comment raised in UAT v8.1 iteration 1 - Direct users to the top of the screen so they can more easily find error message when at the bottom of the screen Improvement Minor ECT-3160 Improvement to page help in Section C. Defect Minor ECT-3170 Fix to defect where in section A.3 "Please enter information in English.." disappears from the rest of the fields in that section when more than max characters entered in first free text field Defect Minor ECT-3176 Fix to defect where, when more than the max allowed is entered in any English and multilingual fields, then text entered in other English field appears in Italics Defect Minor ECT-3181 Fix to comment raised in UAT v8.1 iteration 1 - Field name and number should be included in the error message when multilingual text field is filled in but no language selected or vice versa Improvement Minor ECT-3198 EudraCT Number - Revise error message so clearer when user enters a EudraCT number which is in correct format but does not exist. Defect Minor ECT-3210 3rd Country BI Template - Font size of Trial Identification corrected to be the same as the rest of the section headers EMA/745095/2011 Page 4/5

Defect Minor ECT-3245 In validation report text labels for sections "D8" and "D9" corrected to add ".", i.e. "D.8" and "D.9". Defect Minor ECT-3182 Fix to UAT comment: Sponsors Protocol Code Number on Trial Identification section accepts spaces Defect Minor ECT-3250 language drop down list in the CTA form to be in alphabetical order Defect Minor ECT-3249 Email address entered in C.1.5.1.1 is cleared out if value selected from drop down menu in C.1.1, C.1.2, C.1.3 Defect Minor ECT-3179 Help icon text for A.2 EudraCT Number has incorrect reference to section A.7 as resubmission (corrected to A.6). Defect Minor ECT-3226 Correction to minor formatting issue in C1 header of PDF. Defect Minor ECT-3252 Correction to URL extending out of the help text window when user hovers over MedDRA information in section E.1.2. Defect Minor ECT-3223 Removal of non-printable character in help text for Section C. Additional information None. Installation steps deviating from the deployment guide None. EMA/745095/2011 Page 5/5